EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early biopsychological changes during masculinizing gender-affirming hormone therapy in AFAB transgender individuals: a 4-month prospective study

Ludek Fiala, Daniela Kestlerova, Jakub Nespor, Jiri Lenz

Frontiers in Psychiatry · 17.06.2026 · 17

DOI: 10.3389/fpsyt.2026.1847778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 17.06.2026. Verfasst von Ludek Fiala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatric Clinic, Department of Sexology, Faculty of Medicine, Charles University, Pilsen, Czechia. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Transgender individuals frequently experience elevated levels of psychological distress, including anxiety and trauma-related symptoms. Gender-affirming hormone therapy (GAHT) has been associated with improvements in mental health and quality of life; however, early biopsychological changes occurring during the initial phase of masculinizing hormone therapy remain insufficiently understood. The present exploratory longitudinal study investigated early endocrine and psychological changes in transgender individuals assigned female at birth undergoing masculinizing GAHT.

Methods

We conducted a 4-month prospective observational study involving 30 transgender individuals assigned female at birth initiating masculinizing GAHT. Participants were assessed at baseline (prior to treatment initiation), after 2 months, and after 4 months of therapy. Hormonal parameters (estradiol, testosterone, prolactin) and psychological measures including anxiety (HAM-A), trauma-related symptoms (TSC-40), and quality of life (MANSA) were evaluated. Due to the exploratory character of the study and the relatively small sample size, analyses were performed primarily using non-parametric statistical methods, including repeated-measures analyses.

Results

During follow-up, expected endocrine changes were observed, including decreased estradiol levels and increased testosterone concentrations. These changes were accompanied by reductions in anxiety and trauma-related symptoms and by improvements in quality of life measures over time. Repeated-measures analyses demonstrated significant longitudinal improvements in psychological outcomes across follow-up assessments (p < 0.05). Exploratory associations between hormonal and psychological variables appeared more pronounced after 4 months of treatment, particularly for estradiol in relation to anxiety and quality of life. Earlier assessments demonstrated weaker and less consistent associations. Psychological improvements were not directly proportional to the magnitude of hormonal changes alone, suggesting that psychosocial and treatment-related factors may also contribute to early adaptation during GAHT.

Conclusion

Early masculinizing GAHT in transgender individuals assigned female at birth was associated with favorable endocrine and psychological changes during the first 4 months of treatment. The findings support a complex and potentially time-dependent relationship between hormonal alterations and psychological adaptation during early transition. Given the exploratory nature and limited sample size of the present study, further longitudinal research with larger cohorts and comparison groups is needed to clarify the underlying biopsychological mechanisms of GAHT.

Schlagwörter

Stichwörter der Autor:innen

anxietygender-affirming hormone therapyquality of lifetransgender mentrauma-related symptoms

Autor:innen und Institutionen

  • Psychiatric Clinic, Department of Sexology, Faculty of Medicine, Charles University, Pilsen, Czechia.
  • Institute of Sexology, Faculty Hospital, First Faculty of Medicine, Charles University, Prague, Czechia.
  • Department of Pathology, Znojmo Hospital, Znojmo, Czechia.
  • Department of Anatomy, Histology and Embryology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czechia.

Zitieren

APA

Fiala, L., Kestlerova, D., Nespor, J., & Lenz, J. (2026). Early biopsychological changes during masculinizing gender-affirming hormone therapy in AFAB transgender individuals: a 4-month prospective study. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1847778

Vancouver

Fiala L, Kestlerova D, Nespor J, Lenz J. Early biopsychological changes during masculinizing gender-affirming hormone therapy in AFAB transgender individuals: a 4-month prospective study. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1847778

BibTeX
@article{Fiala2026,
  author = {Fiala, Ludek and Kestlerova, Daniela and Nespor, Jakub and Lenz, Jiri},
  title = {Early biopsychological changes during masculinizing gender-affirming hormone therapy in AFAB transgender individuals: a 4-month prospective study},
  journal = {Frontiers in Psychiatry},
  year = {2026},
  volume = {17},
  doi = {10.3389/fpsyt.2026.1847778}
}
Kostenlos starten →